Prevalence of Psychosis and its Association with Cannabis Dependence Syndrome

Jump To References Section

Authors

  • Bhupendra Singh
     Department of Psychiatric Social Work, Institute of Mental Health, Pt. B D Sharma University of Health Sciences, Rohtak, Haryana ,IN
  • Upendra Singh
     Department of Psychychiatric Social Work, CEIMH, ABVIMS, Dr. RML Hospital, New Delhi ,IN
  • Sweta
     Department of Clinical Psychology, Chacha Neharu Bal Chikitsalay, Delhi ,IN

Keywords:

cannabis dependence, prevalence, psychosis, hospitalization

Abstract

One may find it amusing that cannabis has been used traditionally in India since the Vedic period and texts of Ayurveda mention the use of cannabis. However, cannabis use has been linked with fundamental brain functioning and associated with anincreased risk of psychotic disorder. To assess the association between cannabis dependence syndrome and the prevalence of psychosis. The study was a cross-sectional hospital based study. The sample size comprised 260 individuals diagnosed with cannabis dependence syndrome, using purposive sampling techniques. Tools used were the Brief Psychiatric Rating Scale and Cannabis Use Disorder Identification Test. Study results show regular and high use of cannabis is associated with the prevalence of psychotic symptoms. The prevalence of psychosis among the selected individuals of cannabis users was highly prone than among the general population in India. Cannabis dependence syndrome is a particularly high risk group for psychotic disorders.

Downloads

Published

2024-09-02

Issue

Volume 15, Issue 2, June 2024

Section

Articles

 

References

Adamson, S. J., & Sellman, J. D. (2003). A prototype screening instrument for cannabis use disorder: The Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug and Alcohol Review, 22(3), 309-315.

Ambekar, A., Agrawal, A., Rao, R., Mishra, A. K., Khandelwal, S. K., &Chadda, R. K. (2019). Magnitude of substance use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India, 23.

Borges, G., Bagge, C. L., & Orozco, R. (2016). A literature review and meta-analyses of cannabis use and suicidality. Journal of Affective Disorders, 195, 63-74.

Bussink, C., Carpentier, C., Davalos, L. M., Davis, P., Duran-Martinez, A., Eichinger, N., & Vella, A. (2016). United Nations office on drugs and crime. New York: World Drug Report.

Cougle, J. R., Hakes, J. K., Macatee, R. J., Chavarria, J., & Zvolensky, M. J. (2015). Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: An analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Journal of Psychiatric Research, 66, 135-141.

Delforterie, M. J., Lynskey, M. T., Huizink, A. C., Creemers, H. E., Grant, J. D., Few, L. R., & Agrawal, A. (2015). The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug and Alcohol Dependence, 150, 98-104.

Di Forti, M., Lappin, J. M., & Murray, R. M. (2007). Risk factors for schizophreniaall roads lead to dopamine. European Neuropsychopharmacology, 17, S101-S107.

Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., & Mayo, N. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry, 76(4), 426-434.

Hall, W., & Degenhardt, L. (2007). Prevalence and correlates of cannabis use in developed and developing countries. Current Opinion in Psychiatry, 20(4), 393397.

Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population-a meta-analysis of 31 studies. BMC Psychiatry, 14, 1-22.

Kuepper, R., van Os, J., Lieb, R., Wittchen, H. U., Höfler, M., & Henquet, C. (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ (Clinical Research ed.), 342, d738. https://doi.org/10.1136/bmj.d738.

Leadbeater, B. J., Ames, M. E., & Linden‐Carmichael, A. N. (2019). Age‐varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction, 114(2), 278-293.

Malik, A. R. (2006). Gone to pot: The association between cannabis and psychosis. Psychiatric Times, 28-28.

Mechoulam, R., Spatz, M., & Shohami, E. (2002).Endocannabinoids and neuroprotection. Science's STKE, 2002(129), re5-re5.

National Academies of Sciences, Medicine Division, Board on Population Health, Public Health Practice, Committee on the Health Effects of Marijuana, An Evidence Review, & Research Agenda (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies.

Overall, J. E., & Gorham, D. R. (1962).The brief psychiatric rating scale. Psychological Reports, 10(3), 799-812.

Patel, S., Khan, S., Saipavankumar, M., Hamid, P., & Hamid, P. (2020). The association between cannabis use and schizophrenia: Causative or curative? A systematic review. Cureus, 12, 7.

Ray, R. (2004). The extent, pattern and trends of drug abuse in India: National survey. Ministry of Social Justice and Empowerment, Government of India & United Nations Office on Drugs and Crime, Regional Office for South Asia.

Rhew, I. C., Fleming, C. B., Vander Stoep, A., Nicodimos, S., Zheng, C., & McCauley, E. (2017). Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community‐based cohort. Addiction, 112(11), 1952-1960.

Shalit, N., Shoval, G., Shlosberg, D., Feingold, D., & Lev-Ran, S. (2016). The association between cannabis use and suicidality among men and women: A population-based longitudinal study. Journal of Affective Disorders, 205, 216-224.

Shrivastava, A., Johnston, M., Terpstra, K., & Bureau, Y. (2014). Cannabis and psychosis: Neurobiology. Indian Journal of Psychiatry, 56(1), 8-16.

Singh, S., & Balhara, Y. P. S. (2017). A review of Indian research on co-occurring cannabis use disorders and psychiatric disorders. Indian Journal of Medical Research, 146(2), 186-195.

Womack, S. R., Shaw, D. S., Weaver, C. M., & Forbes, E. E. (2016).Bidirectional associations between cannabis use and depressive symptoms from adolescence through early adulthood among at-risk young men. Journal of Studies on Alcohol and Drugs, 77(2), 287-297.

World Health Organization (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines (Vol. 1). World Health Organization.